Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypersexuality with antiparkinsonian therapy.

R J Uitti1, C M Tanner, A H Rajput

  • 1Department of Neurology, Mayo Clinic, Rochester, Minnesota.

Clinical Neuropharmacology
|October 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Culturally adapted psychosocial interventions (CaPSI) for early psychosis in a low-resource setting: study protocol for a large multi-center RCT.

BMC psychiatry·2023
Same author

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Movement disorders : official journal of the Movement Disorder Society·2017
Same author

Revue neurologique·2017
Same author

Charcot, hysteria, and simulated disorders.

Handbook of clinical neurology·2016
Same author

Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.

European journal of neurology·2014
Same author

Continuous in-home monitoring of essential tremor.

Parkinsonism & related disorders·2013

Anti-parkinsonian drugs can cause hypersexuality in patients with Parkinson

Area of Science:

  • Neurology
  • Neuropharmacology

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder affecting motor control.
  • Treatment for PD often involves dopaminergic medications.

Observation:

  • Thirteen patients with Parkinson's disease developed hypersexuality during anti-parkinsonian therapy.
  • This behavior became a concern for families or social agencies.

Findings:

  • Hypersexuality was dose-dependent on anti-parkinsonian drugs in most patients.
  • No correlation was found between improved motor function and increased sexual behavior.
  • Pre-existing psychiatric conditions or brain damage did not predict this side effect.

Implications:

  • Hypersexuality may be linked to prolactin secretion inhibition by these drugs.

Related Experiment Videos

  • Clinicians should monitor for and discuss sexual side effects during Parkinson's treatment.
  • Further research is needed to understand the neurobiological mechanisms involved.